INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 414m ago
HOUSE PTR14m ago
SEC 13F14m ago
ROBINHOOD CHAIN14m ago
SEC FORM 4/Grant or awardVerified data

Quan Joanne reported MIRM

CHIEF MEDICAL OFFICER · Mirum Pharmaceuticals, Inc. · Mirum Pharmaceuticals, Inc. — Performance Restricted Stock Units

Side
A
Value
—
Shares
20.0K
Price
—
Executed
Jan 28, 2026
Disclosed
Jan 30, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Jan 28 executedJan 30, 2026 disclosed

MIRM · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
5/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Grant or award — administrative, little informational value

  • Relative size+1 / 25

No reported dollar value · new position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    1 prior trade recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · MIRM

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    6
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M$59K
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    11
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise · 10b5-1 plan
    		M—
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    18
    PC
    Peetz ChristopherDirector, CHIEF EXECUTIVE OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$1.80M
    20.0K sh
    		Nov 4, 2026Nov 4, 2026
    traded Nov 4, 2026
    		+0dSEC FORM 4

    Evidence

    23
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M$310K
    16.1K sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M—
    16.1K sh
    		Oct 16, 2026Oct 19, 2026
    traded Oct 16, 2026
    		+3dSEC FORM 4

    Evidence

    15
    MP
    Myers Robert PaulChief Medical Officer
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    40.0K sh
    		Oct 9, 2026Oct 14, 2026
    traded Oct 9, 2026
    		+5dSEC FORM 4

    Evidence

    15
    MP
    Myers Robert PaulChief Medical Officer
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    25.0K sh
    		Oct 9, 2026Oct 14, 2026
    traded Oct 9, 2026
    		+5dSEC FORM 4

    Evidence

    38
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale
    		SELL$4.00M
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M—
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    23
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M$251K
    40.0K sh
    		Aug 18, 2026Aug 19, 2026
    traded Aug 18, 2026
    		+1dSEC FORM 4

    Evidence

    15
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Open-market sale · 10b5-1 plan
    		SELL$264K
    2,594 sh
    		Jun 17, 2026Jun 18, 2026
    traded Jun 17, 2026
    		+1dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    16.3K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    25.1K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    QJ
    Quan JoanneCHIEF MEDICAL OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    11.8K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    RP
    Radovich PeterPRESIDENT AND COO
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    34.5K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    QJ
    Quan JoanneCHIEF MEDICAL OFFICER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    18.1K sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    7,680 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    4,970 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Grant or award
    		A—
    9,000 sh
    		Jan 28, 2026Jan 30, 2026
    traded Jan 28, 2026
    		+2dSEC FORM 4

    Evidence

    5
    HJ
    Howe JolandaSVP, GLOBAL CONTROLLER
    MIRMMirum Pharmaceuticals, Inc.
    Option exercise
    		M—
    1,500 sh
    		Jan 23, 2026Jan 27, 2026
    traded Jan 23, 2026
    		+4dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001670138-26-000003
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Jan 28, 2026
    Published
    Jan 30, 2026
    Ingested by INSIDER
    Nov 5, 04:19 UTC
    Last re-read
    Nov 5, 04:19 UTC

    Extracted facts

    Filer
    Quan Joanne
    Role
    CHIEF MEDICAL OFFICER
    Transaction
    Grant or awardAs filed: “A”
    Asset
    Mirum Pharmaceuticals, Inc. — Performance Restricted Stock Units
    Ticker
    MIRM
    Shares
    20.0K
    Price per share
    $0
    Execution date (reported)
    Jan 28, 2026
    Owned after transaction
    20.0K shares
    Days from execution to publication
    2

    What this establishes

    Quan Joanne filed this Form 4 reporting a grant or award of MIRM on Jan 28, 2026. It became public on Jan 30, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    CHIEF MEDICAL OFFICER
    Quan Joannecik:0001670138
    Issuer
    Mirum Pharmaceuticals, Inc.cik:0001759425

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.